Xu et al. established PLK4 overexpression in multiple myeloma cells, which, when blocked, reduced cell viability, induced apoptosis, and amplified the sensitivity of multiple myeloma cells to chemotherapy.118. This evidence concerns the gene PLK4 and plasma cell myeloma.